V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008982 | 260005905 | null | 72.4 | Palliative (P) | 2017-01-10 | 2017-01-21 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260028988 | NOT MATCHED |
| 260008983 | 260005905 | 1.48 | 57.6 | Adjuvant (A) | 2018-01-12 | 2018-01-20 | FEC 100 | N | N | 260028988 | PMITCEBO-R |
| 260008984 | 260005905 | null | 78.2 | Disease modification (D) | 2015-04-16 | 2015-04-28 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | Y | N | 260028988 | HYDROXYCARBAMIDE |
| 260008985 | 260005906 | null | 82 | Curative (C) | null | 2018-07-04 | Carboplatin + Etoposide iv&po | null | null | 260028993 | CISPLATIN + ETOPOSIDE |
| 260008986 | 260005906 | 1.74 | 84.7 | Curative (C) | 2013-07-23 | 2013-07-26 | CHLORAMBUCIL + RITUXIMAB | N | N | 260028993 | RITUXIMAB |
| 260008987 | 260005907 | null | 57.1 | Curative (C) | null | 2018-02-01 | Rituximab | null | null | 260028998 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008988 | 260005907 | 1.49 | 81.9 | Curative (C) | 2016-05-09 | 2016-05-22 | CODOX M | N | N | 260028998 | CHLORAMBUCIL |
| 260008989 | 260005908 | null | 80.2 | Not known (9) | 2014-06-23 | 2014-07-05 | Rituximab | 02 | N | 260029002 | RITUXIMAB |
| 260008990 | 260005909 | 1.85 | 79 | Curative (C) | 2016-10-29 | 2016-11-01 | R Chlorambucil | 02 | null | 260029004 | RITUXIMAB |
| 260008991 | 260005909 | 1.56 | 80.7 | Curative (C) | 2015-05-20 | 2015-05-22 | Rituximab | 02 | N | 260029004 | RITUXIMAB |
| 260008992 | 260005909 | 1.84 | 74.8 | Curative (C) | 2017-04-15 | 2017-04-15 | Capecitabine + Oxaliplatin 21day | 2 | N | 260029004 | CVP R + GEMCITABINE |
| 260008993 | 260005910 | null | 73.05 | Curative (C) | null | 2017-03-23 | Rituximab | null | null | 260029011 | OXALIPLATIN + MDG |
| 260008994 | 260005911 | 1.64 | null | Adjuvant (A) | 2014-09-21 | 2014-09-21 | Cisplatin + Etoposide (5 day) | null | N | 260029013 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008995 | 260005912 | 1.47 | 66.3 | Curative (C) | 2015-12-02 | 2015-12-02 | Rituximab | N | N | 260029014 | CHOP |
| 260008996 | 260012107 | null | 50.5 | Curative (C) | null | 2018-10-27 | PEMBROLIZUMAB | null | null | 260029017 | TRIAL |
| 260008997 | 260005913 | 1.63 | 77.7 | null | null | 2014-04-19 | GALLIUM TRIAL | Y | N | 260029020 | RITUXIMAB |
| 260008998 | 260005913 | 1.73 | 65.2 | Palliative (P) | 2018-06-18 | 2018-07-03 | Rituximab (Maintenance) | N | N | 260029020 | NOT MATCHED |
| 260008999 | 260005913 | 1.74 | null | Disease modification (D) | 2014-02-19 | 2014-03-22 | Rituximab | N | N | 260029020 | GEMCITABINE + VINORELBINE |
| 260009000 | 260005914 | 1.65 | 68 | Curative (C) | 2015-05-28 | 2015-06-13 | Trial Unspecified | 02 | N | 260029024 | RITUXIMAB |
| 260009001 | 260005914 | 1.75 | 85.5 | Adjuvant (A) | 2016-02-20 | 2016-02-20 | R Chlorambucil | N | N | 260029024 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB |
| 260009002 | 260005915 | 1.64 | 73.05 | Curative (C) | null | 2018-06-29 | Rituximab | null | null | 260029028 | CHLORAMBUCIL |
| 260009003 | 260012110 | 1.63 | 49.9 | Palliative (P) | 2013-11-02 | 2013-11-12 | Rituximab | 02 | Y | 260029029 | RITUXIMAB |
| 260009004 | 260005916 | 1.86 | 93.5 | Adjuvant (A) | 2014-06-25 | 2014-06-25 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260029030 | RITUXIMAB |
| 260009005 | 260005917 | 1.65 | null | Disease modification (D) | 2017-10-16 | 2017-10-17 | R-CHOEP | N | N | 260029032 | RITUXIMAB |
| 260009006 | 260005918 | 1.69 | 73.8 | Curative (C) | 2018-03-13 | 2018-03-13 | Rituximab | 2 | N | 260029033 | CISPLATIN + ETOPOSIDE |
| 260009007 | 260012111 | 1.84 | null | null | null | 2015-09-27 | Rituximab | null | null | 260029036 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260009008 | 260005919 | 1.74 | 84 | Curative (C) | 2017-02-28 | 2017-02-28 | R ABVD | N | Y | 260029037 | RITUXIMAB |
| 260009009 | 260005920 | 1.87 | 75.4 | Curative (C) | 2018-05-01 | 2018-05-02 | Bendamustine +/- Prednisolone | null | N | 260029039 | CYTARABINE HIGH DOSE |
| 260009010 | 260005920 | 1.6 | 89 | Curative (C) | 2016-07-18 | 2016-07-18 | Rituximab | 02 | N | 260029039 | CISPLATIN + ETOPOSIDE |
| 260009011 | 260005920 | 1.63 | 60 | Curative (C) | 2014-06-15 | 2014-06-20 | Rituximab | N | N | 260029039 | CHLORAMBUCIL |
| 260009012 | 260005921 | null | null | null | 2017-10-16 | 2017-10-16 | Rituximab | N | N | 260029046 | RITUXIMAB |
| 260009013 | 260005921 | 1.77 | 80.2 | null | 2015-08-17 | 2015-08-20 | BORTEZOMIB + THALIDOMIDE | 02 | N | 260029046 | GDP |
| 260009014 | 260005922 | 1.67 | 88 | Adjuvant (A) | 2016-07-27 | 2016-07-29 | Rituximab | N | N | 260029048 | RITUXIMAB |
| 260009015 | 260005922 | 1.7 | 77.2 | Disease modification (D) | 2014-12-12 | 2014-12-24 | Rituximab (INTRAVENOUS Maintenance) | N | N | 260029048 | CVD |
| 260009016 | 260005923 | 1.65 | 61.7 | Palliative (P) | 2016-02-23 | 2016-02-23 | Rituximab | 02 | N | 260029051 | DOXORUBICIN + OLARATUMAB |
| 260009017 | 260005923 | 1.53 | 58 | Palliative (P) | null | 2014-07-01 | Cisplatin + Radiotherapy | N | N | 260029051 | FEC |
| 260009018 | 260005923 | 1.88 | 80.2 | Disease modification (D) | 2015-03-20 | 2015-03-21 | CISPLATIN + ETOPOSIDE | 2 | N | 260029051 | RITUXIMAB |
| 260009019 | 260005924 | 1.83 | 52.9 | Curative (C) | 2018-01-18 | 2018-01-21 | CYCLOPHOSPHAMIDE | N | N | 260029062 | R-EPOCH |
| 260009020 | 260005924 | null | 55.8 | Curative (C) | 2018-01-20 | 2018-01-20 | BENDAMUSTINE | null | null | 260029062 | PMITCEBO-R |
| 260009021 | 260005924 | 2.05 | 80.2 | Disease modification (D) | 2017-09-10 | 2017-09-22 | null | N | N | 260029062 | TRIAL |
| 260009022 | 260005925 | 1.71 | 75.3 | Disease modification (D) | 2017-04-02 | 2017-04-07 | CISPLATIN + ETOPOSIDE | 2 | N | 260029066 | EP |
| 260009023 | 260012117 | null | 68 | Curative (C) | 2016-12-08 | 2017-01-05 | Rituximab | N | N | 260029067 | CHOP |
| 260009024 | 260005926 | 1.66 | 101 | Disease modification (D) | 2015-01-11 | 2015-01-18 | null | 02 | N | 260029070 | CYCLOPHOSPHAMIDE |
| 260009025 | 260005926 | 1.65 | 0 | Curative (C) | 2018-05-31 | 2018-05-31 | Chlorambucil + Pred + Rituximab | N | N | 260029070 | CODOX M |
| 260009026 | 260005927 | 1.53 | null | Palliative (P) | 2016-03-22 | 2016-03-23 | Rituximab | N | N | 260029076 | LENALIDOMIDE |
| 260009027 | 260005927 | 1.78 | 57.8 | Palliative (P) | 2015-01-09 | 2015-01-12 | PACIFICO TRIAL | 2 | N | 260029076 | RITUXIMAB |
| 260009028 | 260005928 | 1.82 | 122.7 | Palliative (P) | 2017-02-12 | 2017-02-18 | CISPLATIN + ETOPOSIDE | N | N | 260029078 | RITUXIMAB |
| 260009029 | 260005928 | 1.78 | 112.4 | Curative (C) | 2015-10-28 | 2015-11-02 | Rituximab (Maintenance) | 02 | N | 260029078 | ABVD |
| 260009030 | 260005928 | 1.78 | 67.4 | Curative (C) | 2018-05-19 | 2018-06-02 | FCR | 02 | Y | 260029078 | RITUXIMAB |
| 260009031 | 260005928 | 1.78 | 67.7 | null | 2013-09-22 | 2013-09-23 | Temozolomide + RT | 02 | null | 260029078 | CARBOPLATIN + ETOPOSIDE |